Stereotaxis, Inc. (NYSEAMERICAN:STXS) Sees Significant Decrease in Short Interest

Stereotaxis, Inc. (NYSEAMERICAN:STXS) saw a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 2,540,000 shares, a drop of 17.3% from the November 15th total of 3,070,000 shares. Based on an average daily volume of 291,600 shares, the short-interest ratio is presently 8.7 days. Currently, 3.6% of the company’s stock are short sold.

Stereotaxis Stock Performance

STXS opened at $2.34 on Friday. Stereotaxis has a 52-week low of $1.63 and a 52-week high of $3.29.

Stereotaxis (NYSEAMERICAN:STXS) last posted its quarterly earnings results on Monday, November 11th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.03). The firm had revenue of $9.20 million for the quarter, compared to the consensus estimate of $6.80 million. Stereotaxis had a negative return on equity of 162.54% and a negative net margin of 85.79%. On average, sell-side analysts expect that Stereotaxis will post -0.26 earnings per share for the current year.

Institutional Investors Weigh In On Stereotaxis

Several hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in Stereotaxis by 7.7% during the first quarter. Vanguard Group Inc. now owns 2,613,966 shares of the company’s stock worth $6,822,000 after acquiring an additional 187,437 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in Stereotaxis by 247.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock worth $345,000 after purchasing an additional 135,041 shares during the last quarter. Forum Financial Management LP bought a new stake in Stereotaxis in the 2nd quarter valued at $48,000. Rhumbline Advisers boosted its stake in Stereotaxis by 645.6% in the 2nd quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock valued at $88,000 after purchasing an additional 41,780 shares during the period. Finally, Renaissance Technologies LLC grew its holdings in Stereotaxis by 46.2% in the 2nd quarter. Renaissance Technologies LLC now owns 488,700 shares of the company’s stock valued at $889,000 after buying an additional 154,400 shares in the last quarter. Institutional investors and hedge funds own 45.35% of the company’s stock.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.